Mutational Analysis of Proapoptotic bcl-2 Family genes in Colon Carcinomas.
- Author:
Young Hwa SOUNG
1
;
Jong Woo LEE
;
Su Young KIM
;
Suk Woo NAM
;
Won Sang PARK
;
Jung Young LEE
;
Nam Jin YOO
;
Sug Hyung LEE
Author Information
1. Department of Pathology, College of Medicine, The Catholic University of Korea, Seoul, Korea. suhulee@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Colonic neoplasms;
Genes;
bcl-2;
Apoptosis;
Mutation
- MeSH:
Adenocarcinoma;
Apoptosis;
Base Sequence;
Clinical Coding;
Colon*;
Colonic Neoplasms;
Colorectal Neoplasms;
Humans;
Mitochondria;
Polymerase Chain Reaction;
Polymorphism, Single-Stranded Conformational;
Puma;
Sequence Analysis, DNA
- From:Korean Journal of Pathology
2005;39(3):168-171
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Several lines of evidence have indicated that the deregulation of apoptosis is involved in the mechanisms of cancer development, and somatic mutations of the apoptosisrelated genes have been reported in human cancers. Members of the bcl-2 family proteins regulate the intrinsic apoptosis pathway mainly in the mitochondria. The aim of this study was to explore whether the somatic mutation of the proapoptotic bcl-2 family genes, one of the mechanisms that prolong the survival of cancer cells, occurred in colorectal carcinomas. METHODS: In the current study, to detect the somatic mutations in the DNA sequences encoding the bcl-2 homology 3 (BH3) domain of the human bak, bid, bik, bim, PUMA, bcl-rambo, bcl-G, and bmf genes in 98 colon adenocarcinomas, we used polymerase chain reaction (PCR), single strand conformation polymorphism (SSCP), and DNA sequencing. RESULTS: The SSCP analysis detected no evidence of somatic mutations of the genes in the coding regions of the BH3 domain in the cancers. CONCLUSIONS: The data presented here indicate that the proapoptotic bcl-2 family genes, bak, bid, bik, bim, PUMA, bcl-rambo, bcl-G and bmf may not be somatically mutated in human colorectal carcinomas, and suggest that the colorectal cancers may not utilize mutational events of these proapoptotic bcl-2 family genes in the mechanisms for evading apoptosis.
